SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CAH

Cardinal Health Inc (New York Stock Exchange:CAH)

US · Delayed Price · Currency is USD
Also listed: 0HTG.LHealthcare · Medical - Distribution
$275.54+$3.20 (+1.18%)
 
Market cap
$63.7B
Insider Score
Health Score
Analyst consensus
Listed since
Aug 4, 1983
Market Cap$63.69B+32.5%
Revenue (ttm)$257.75B+10.0%
Net Income$1.82B+14.0%
EPS$7.72+16.4%
Shares Out231.14M
PE Ratio35.55
Forward PE19.12
Dividend$2.05(0.75%)
Ex-Dividend DateJan 4, 2027
Volume413,194
Open$276.52
Previous Close$272.34
Day's Range$273.46 - $276.52
52-Week Range$180.45 - $286.29
Beta0.52
AnalystsBuy
Price Target$288.27(+4.62%)
Earnings DateFeb 4, 2027
+1.18% (1D)
No price history available.

About CAH

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

Address
7000 Cardinal Place, Dublin, OH, 43017, US
Market Cap
63.69 billion
Employees
61,344
Industrial Classification
Medical - Distribution

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$27.09M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
7 Buy1 Hold0 SellAvg target $279.27 (+1.2%)

8 firms rating CAH in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From CAH’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+1.18%
5 Days
-1.62%
1 Month
+6.99%
6 Months
+38.30%
1 Year
+32.53%

$CAH stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of CAH by members of U.S. Congress

Alan ArmstrongSenate / RPurchase$1.00K – $15.00KMar 27, 2026
Jonathan JacksonHouse / DPurchase$50.00K – $100.00KJan 12, 2024
Jonathan JacksonHouse / DPurchase$50.00K – $100.00KJan 11, 2024
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KMar 18, 2020
Gilbert CisnerosHouse / DPurchase$1.00K – $15.00KMar 18, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KMar 17, 2020

Recently reported changes in CAH holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CAH's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CAH Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CAH Revenue by Segment or Geography

$67.54BTotal
Pharmaceutical and Specialty Solutions$62.58B92.66%
GMPD$3.19B4.72%
Other Operating Segment$1.76B2.61%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CAH patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CAH from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CAH

VOOVanguard S&P 500 ETF$1.55B
VTIVanguard Morningstar Total Stock Market ETF$1.46B
VOVanguard Morningstar Mid-Cap ETF$1.24B
IVViShares Core S&P 500 ETF$853.32M
SPYState Street SPDR S&P 500 ETF$788.49M
VTVVanguard Morningstar Value ETF$560.05M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CAH’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
78
News & Sentiment
20% of score
58

News check: Analyst upgrades on price targets offset medical device recalls; mixed but slightly bullish on fundamentals.

Recent Insider Activity

Buys
0
Sells
18
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

EGGSNestYield Total Return Guard ETF6.86%
PEZInvesco Dorsey Wright Consumer Cyclicals Momentum ETF5.84%
EASYLiberty One Defensive Dividend Growth ETF5.44%
HLTHTema Healthcare AI ETF4.84%
FXGFirst Trust Consumer Staples AlphaDEX Fund4.76%
BTALAGF U.S. Market Neutral Anti-Beta Fund4.73%
HIG.TOBrompton Global Healthcare Income & Growth ETF4.60%
HIG-U.TOBrompton Global Healthcare Income & Growth ETF4.60%
GBLOGlobal Beta Low Beta ETF4.57%
BASVBrown Advisory Sustainable Value ETF4.21%
GBDVGlobal Beta Smart Income ETF4.17%
BLCRiShares Large Cap Core Active ETF4.09%

Weight is the stock’s share of each fund’s holdings.